Serevent(TM) 50mg bid significantly reduces moderate-severe exacerbations in patients with all severities of COPD

Robert Stockley, PJ Whitehead, MK Williams, G Hagan

Research output: Contribution to conference (unpublished)Paper

Original languageEnglish
PagesA949
Publication statusPublished - 1 Jan 2003

Cite this